¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"leucine hypoglycemia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® hypoglycemia ÇÑ±Û ÀúÇ÷´ç(Áõ)
¼³¸í   
  Ç÷¾×¼ÓÀÇ ´ç·®ÀÌ º´ÀûÀ¸·Î °¨¼ÒµÇ¾î Àִ »óÅÂ. Á¤»óÀÎÀÇ °æ¿ì À̸¥ ¾ÆÄ§ °øº¹½Ã Ç÷´çÄ¡´Â 60~100mg/dL À̸砽ÄÈÄ¿¡µµ 160mg/dL ÀÌÇÏÀÌ´Ù. ±×·±µ¥ Ç÷´çÄ¡°¡ 50mg/dL ÀÌÇϷΠ¶³¾îÁø °æ¿ì ÀúÇ÷´çÀ̶ó°í Çϰí, À̷ΠÀÎÇØ ½Å°æÁõ¼¼°¡ ³ªÅ¸³ª´Â °ÍÀ» ÀúÇ÷´çÁõÀ̶ó ÇÑ´Ù. ½ÄÀº¶¡-°øº¹°¨-Å»·Â°¨-Çö±âÁõ µîÀÇ Áõ¼¼°¡ ³ªÅ¸³ª°í, µåµð¾î´Â Àü½Å°æ·Ã-È¥¼ö¿¡ ºüÁö¸ç, ¿À·¡ °è¼ÓµÇ¸é »ç¸ÁÇÑ´Ù. Àν¶¸°À̳ª Ç÷´ç°­ÇÏÁ¦ÀÇ °úÀ×Åõ¿©¿¡ ÀÇÇÏ¿© ÀϾ´Â °æ¿ì°¡ ¸¹°í, À̵頾àÁ¦·Î Ä¡·á Áß¿¡ Àִ ´ç´¢º´ È¯ÀÚ°¡ ½Ä»ç µîÀ» °É·¯ °øº¹ÀÏ ¶§¿¡ ÀϾ´Â ¿Ü¿¡, ÀÌÀÚÀÇ Á¾¾ç µîÀ¸·Î Àν¶¸°ÀÌ °úÀ׺кñµÉ ¶§¿¡ ÀϾ´Â °æ¿ìµµ ÀÖ´Ù. ÀúÇ÷´ç¹ßÀÛÀ» ÀÏÀ¸Å² ¶§´Â »çÅÁ¼·Ãë-Æ÷µµ´ç Á¤¸ÆÁֻ砵 ÀÇÇÏ¿© ½Å¼ÓÇϰԠȸº¹µÇ´Â ¼ö°¡ ¸¹´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leucine sensitive hypoglycemia
    ·ù½Å¹Î°¨ÀúÇ÷´ç(Áõ)
  • leucine
    ·ù½Å
  • alimentary hypoglycemia
    ½Ä»çÀúÇ÷´ç
  • exogenous hypoglycemia
    ¿ÜÀÎÀúÇ÷´ç
  • fasting hypoglycemia
    °øº¹ÀúÇ÷´ç
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • postprandial hypoglycemia
    ½ÄÈÄÀúÇ÷´ç(Áõ)
  • reactive hypoglycemia
    ¹ÝÀÀÀúÇ÷´ç(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • fasting hypoglycemia
    °øº¹ÀúÇ÷´ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leucine sensitivity hypoglycemia
    ·ù½Å¹Î°¨ÀúÇ÷´çÁõ
  • leucine
    ·ù½Å
  • alcohol-induced hypoglycemia
    ¾ËÄÚ¿ÃÀ¯µµÀúÇ÷´ç
  • alimentary hypoglycemia
    ½Ä»çÀúÇ÷´ç
  • exogenous hypoglycemia
    ¿ÜÀÎÀúÇ÷´ç
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • organic hypoglycemia
    ±âÁúÀûÀúÇ÷´ç
  • postprandial hypoglycemia
    ½ÄÈÄÀúÇ÷´ç
  • reactive hypoglycemia
    ¹ÝÀÀÀúÇ÷´çÁõ
  • spontaneous hypoglycemia
    ÀÚ¹ßÀúÇ÷´ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Leucine
    ·ù½Å
  • Functional hypoglycemia
    ±â´É¼º ÀúÇ÷´çÁõ(¡­î¸úìÓØñø)
  • Hypoglycemia
    ÀúÇ÷´ç·®
  • alimentary hypoglycemia
    ½Ä»ç¼º ÀúÇ÷´ç.
  • functional hypoglycemia
    ±â´ÉÀû ÀúÇ÷´ç.
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)(î¸úìÓØñø).
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
  • postprandial hypoglycemia
    ½ÄÈļº ÀúÇ÷´ç(¡­î¸úìÓØ).
  • postprandial hypoglycemia
    ½ÄÈļº ÀúÇ÷´ç(ãÝý­àõ î¸úìÓØ)
  • postprandial hypoglycemia
    ½ÄÈļº(ãÝý­àõ) ÀúÇ÷´ç
  • reactive functional hypoglycemia
    ¹ÝÀÀ¼º ±â´É¼º ÀúÇ÷´ç(¡­Ñ¦Òöàõî¸úìÓØ).
  • reactive hypoglycemia
    ¹ÝÀÀ¼º ÀúÇ÷´çÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leucine sensitivity hypoglycemia
    ·ù½Å°¨¼ö¼º ÀúÇ÷´çÁõ.
  • leucine
    ·ù½Å
  • leucine
    ·ç½Å.
  • leucine aminopeptidase
    ·ù½Å¾Æ¹Ì³ëÆéƼµ¥À̽º.
  • leucine test
    ·ù½Å½ÃÇè
  • leucine test
    ·ù½Å½ÃÇè(¡­ãËúÐ).
  • alcohol induced hypoglycemia
    ¾ËÄڿñâÀÎ(¼º) ÀúÇ÷´ç.
  • alimentary hypoglycemia
    ½Ä»ç¼º ÀúÇ÷´ç.
  • exogenous hypoglycemia
    ¿ÜÀμº ÀúÇ÷´ç.
  • functional hypoglycemia
    ±â´ÉÀû ÀúÇ÷´ç.
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)(î¸úìÓØñø).
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • organic hypoglycemia
    ±âÁúÀû ÀúÇ÷´ç(ÐïòõîÜî¼úìÓØ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leucine
    ·ç½Å
  • leucine aminopeptidase
    ·ç½Å¾Æ¹Ì³ëÆéƼµ¥À̽º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HG hand grip; herpes gestationis; Heschl's gyrus; high glucose; human gonadotropin; human growth; hypog...
IHT insulin hypoglycemia test; intravenous histamine test; ipsilateral head turning
PHHI persistent hyperinsulinemic hypoglycemia of infancy
SH Salter-Harris [fracture]; Schonlein-Henoch [purpura]; self-help; serum hepatitis; sexual harassment;...
WHHHIMP Wernicke encephalopathy/withdrawal, hypertensive encephalopathy, hypoglycemia, hypoxemia, intracrani...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IIH Insulin-induced hypoglycemia
SH Severe hypoglycemia
bZIP Basic leucine zipper
bZIP Basic region leucine zipper
HD-Zip Homeo domain-leucine zipper
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute hypoglycemia
    ±Þ¼º ÀúÇ÷´çÁõ
  • hypoglycemia
    Ç÷´ç·® °¨¼Ò, ÀúÇ÷´çÁõ
    Ç÷¾× ÁßÀÇ Æ÷µµ´ç ³óµµ°¡ ºñÁ¤»óÀûÀ¸·Î °¨¼ÒµÈ »óÅ·Î, ÁøÀü, ½ÄÀº ¶¡, ¼Ò¸§, ü¿Â Çϰ­, µÎÅëÀÌ ÀϾ¸ç, Âø¶õ, ȯ°¢, ±â±«ÇÑ ÇൿÀ» ¼ö¹ÝÇϰí ÃÖÈÄ¿¡´Â °æ·Ã, È¥¼ö·Î µÈ´Ù.
  • late postprandial hypoglycemia
    ½ÄÈÄ Èıâ ÀúÇ÷´çÁõ
    À§ ÀýÁ¦ ÈÄ º¸°Ô µÇ´Â Èı⠴ýÇÎ Áõ»óÀÇ Çϳª.
  • leucine
    ·ù½Å
    1. 2-amino-4-methyl
  • leucine-enkephalin-like immunoreactivity
    ·ÎÀ̽Å-¿£ÄÉÆÈ¸° À¯»ç ¸é¿ª ¹ÝÀÀ
  • pentapeptides leucine-enkephalin
    ÆæÅ¸ ÆéƼµå ·çÀ̽Å-¿£ÄÉÆÈ¸°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
C-terminal leucine protein methyltransferase <enzyme> Reversibly modifies protein phosphatase 2a by methyl esterification at its c-terminal leucine residues
Registry number: EC 2.1.1.-
Synonym: tlp methyltransferase
(26 Jun 1999)
dual leucine zipper bearing kinase <enzyme> A serine/threonine kinase but hybrid between microtubule-associated protein kinase kinase kinases and the fibroblast growth factor receptor family; genbank u14636; do not confuse with the neoplasm protein dlk
Registry number: EC 2.7.10.-
Synonym: dlk kinase
(26 Jun 1999)
enkephalin, leucine <chemical> Tyrosylglycylglycylphenylalanylleucine. Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is leucine.
Chemical name: L-Leucine, N-(N-(N-(N-L-tyrosylglycyl)glycyl)-L-phenylalanyl)-
(12 Dec 1998)
enkephalin, leucine-2-alanine <chemical> N-(n-(n-(n-l-tyrosyl-d-alanyl)glycyl)-l-phenylalanyl)-d-leucine. A synthetic delta-selective opioid peptide with analgesic properties. Treatment with dadle results in transient depression of mean arterial blood pressure and heart rate.
Chemical name: D-Leucine, N-(N-(N-(N-L-tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)-
(12 Dec 1998)
leucine <amino acid> The most abundant amino acid found in proteins. Confers hydrophobicity and has a structural rather than a chemical role.
(18 Nov 1997)
leucine 2,3-aminomutase <enzyme> Leucine is converted to 3-amino-4-methylpentanoate (beta leucine)
Registry number: EC 5.4.3.7
(26 Jun 1999)
leucine acetyltransferase <enzyme> Forms acetyl-l-leucine from acetyl-CoA plus leucine
Registry number: EC 2.3.1.-
Synonym: leucine acyltransferase
(26 Jun 1999)
leucine aminopeptidase <enzyme> An exopeptidase that removes neutral amino acid residues from the N terminus of proteins.
(18 Nov 1997)
leucine dehydrogenase <enzyme> An enzyme that catalyses the reaction of l-leucine, water, and NAD+ to produce NADH, ammonia, and 4-methyl-2-oxopentanoate; used in the treatment of certain tumours.
(05 Mar 2000)
leucine hypoglycaemia Reduction in blood glucose concentration produced by administration of leucine; believed to reflect the ability of this amino acid to stimulate insulin secretion.
(05 Mar 2000)
leucine-induced hypoglycaemia Rare cause of hypoglycaemia occurring following ingestion of leucine. Seen especially in infants.
(05 Mar 2000)
leucine-trna ligase <enzyme> An enzyme that activates leucine with its specific transfer RNA.
Chemical name: L-Leucine:tRNA(Leu) ligase (AMP-forming)
Registry number: EC 6.1.1.4
(12 Dec 1998)
leucine zipper <molecular biology> Motif found in certain DNA binding proteins. In a region of approximately 35 amino acids, every seventh is a leucine. This facilitates dimerisation of two such proteins to form a functional transcription factor.
Examples of proteins containing leucine zippers are products of the proto-oncogenes myc, fos and jun.
(15 Oct 1997)
leucine zippers Domains in DNA-binding proteins that contain amino acid sequences that show periodic arrays of leucine residues. These residues exist in an alpha-helical conformation, with the leucine side chains extending from one alpha helix interdigitating with those displayed from a similar alpha helix of a second polypeptide, facilitating dimerization.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • leucine
    ·ç½Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á